72 related articles for article (PubMed ID: 8865868)
21. Candidate host marker for peritoneal dissemination.
Hashizume K; Uchiyama A; Sasaki N; Noshiro H; Morisaki T; Tanaka M; Katano M
Anticancer Res; 2002; 22(3):1781-6. PubMed ID: 12168869
[TBL] [Abstract][Full Text] [Related]
22. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
[TBL] [Abstract][Full Text] [Related]
23. Serum cystatin C: a surrogate marker for the characteristics of peritoneal membrane in dialysis patients.
Al-Wakeel JS; Hammad D; Memon NA; Tarif N; Shah I; Chaudhary A
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):227-31. PubMed ID: 19237809
[TBL] [Abstract][Full Text] [Related]
24. Can the creatinine dialysate-to-plasma ratio from the peritoneal equilibration test be replaced by the sodium dialysate-to-plasma ratio and the sodium level in the dialysate?
García R; Miguel A; Oviedo M; Martínez A; Esteve S; Pérez-Contreras J
Adv Perit Dial; 2000; 16():19-21. PubMed ID: 11045254
[TBL] [Abstract][Full Text] [Related]
25. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
26. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
[TBL] [Abstract][Full Text] [Related]
27. [Peritoneal transport properties for glucose and creatinine in Polish children and adolescents on chronic peritoneal dialysis].
Zurowska A; Borzych D; Zagozdzon I; Drozdz D; Ziółkowska H; Boguszewska A; Szczepańska M; Stefaniak E; Jander A; Kiliś-Pstrusińska K
Przegl Lek; 2006; 63 Suppl 3():75-7. PubMed ID: 16898494
[TBL] [Abstract][Full Text] [Related]
28. Diffusion correction of sodium sieving applicable in a peritoneal equilibration test.
Westra WM; Smit W; Zweers MM; Struijk DG; Krediet RT
Adv Perit Dial; 2003; 19():6-9. PubMed ID: 14763025
[TBL] [Abstract][Full Text] [Related]
29. The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients.
Van Biesen W; Van der Tol A; Veys N; Dequidt C; Vijt D; Lameire N; Vanholder R
Clin J Am Soc Nephrol; 2006 Mar; 1(2):269-74. PubMed ID: 17699216
[TBL] [Abstract][Full Text] [Related]
30. Adequacy and nutrition in pediatric peritoneal dialysis.
Cano FJ; Marín VS; Azocar MA; Delucchi MA; Rodriguez EE; Diaz ED; Villegas RC
Adv Perit Dial; 2003; 19():273-8. PubMed ID: 14763078
[TBL] [Abstract][Full Text] [Related]
31. Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.
Yoon SN; Yang CW; Lee SH; Kim YS; Choi EJ; Chang YS; Bang BK
Adv Perit Dial; 1996; 12():39-42. PubMed ID: 8865869
[TBL] [Abstract][Full Text] [Related]
32. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
[TBL] [Abstract][Full Text] [Related]
33. Leptin and plasminogen activator inhibitor-1 levels in children on chronic dialysis.
Agras PI; Baskin E; Cengiz N; Haberal A; Ozbek N
Ren Fail; 2013 Sep; 35(8):1079-84. PubMed ID: 23879619
[TBL] [Abstract][Full Text] [Related]
34. Effect of blood perfusion on diffusive transport in peritoneal dialysis.
Waniewski J; Werynski A; Lindholm B
Kidney Int; 1999 Aug; 56(2):707-13. PubMed ID: 10432412
[TBL] [Abstract][Full Text] [Related]
35. Correlation between effective peritoneal blood flow, blood pressure, and peritoneal transfer rates.
Grzegorzewska AE; Mariak I
Adv Perit Dial; 1996; 12():19-23. PubMed ID: 8865865
[TBL] [Abstract][Full Text] [Related]
36. [Cytomorphologic, cytochemical and functional characteristics of cells from the peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. I. Quantitative and qualitative characteristics of the cells of the peritoneal dialysate].
Sułowicz W
Przegl Lek; 1987; 44(3):326-35. PubMed ID: 3615937
[No Abstract] [Full Text] [Related]
37. Relationship between plasminogen activator inhibitor-1 gene alterations and fibrosis in peritoneal dialysis patients.
Onur Cura D; Yildiz S; Ataman E; Ersan S; Tanrisev M; Ulgenalp A; Camsari T; Ercal D
Ther Apher Dial; 2021 Feb; 25(1):97-102. PubMed ID: 32301223
[TBL] [Abstract][Full Text] [Related]
38. The importance of the interstitium in peritoneal transport.
Flessner MF
Perit Dial Int; 1996; 16 Suppl 1():S76-9. PubMed ID: 8728167
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Changes of PAI-1, MMP-2, and VEGF in Peritoneal Effluents and Their Associations with Peritoneal Small-Solute Transfer Rate in New Peritoneal Dialysis Patients.
Hao N; Chiou TT; Wu CH; Lei YY; Liang PL; Chao MC; Yang H; Chen JB
Biomed Res Int; 2019; 2019():2152584. PubMed ID: 31192253
[TBL] [Abstract][Full Text] [Related]
40. [Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. VI. Functional studies: evaluation of the effect of isolated macrophages on lymphocytes in culture].
Sołowicz W
Przegl Lek; 1987; 44(12):810-6. PubMed ID: 3451304
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
